• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Molecules . Epitope-Based Immunoinformatics Approach on Nucleocapsid Protein of Severe Acute Respiratory Syndrome-Coronavirus-2

tetano

Editor, Senior Moderator
Molecules


. 2020 Nov 2;25(21):E5088.
doi: 10.3390/molecules25215088.
Epitope-Based Immunoinformatics Approach on Nucleocapsid Protein of Severe Acute Respiratory Syndrome-Coronavirus-2


Ahmed Rakib[SUP] 1 [/SUP], Saad Ahmed Sami[SUP] 1 [/SUP], Md Ashiqul Islam[SUP] 1 2 [/SUP], Shahriar Ahmed[SUP] 1 [/SUP], Farhana Binta Faiz[SUP] 1 [/SUP], Bibi Humayra Khanam[SUP] 1 [/SUP], Kay Kay Shain Marma[SUP] 1 [/SUP], Maksuda Rahman[SUP] 1 [/SUP], Mir Muhammad Nasir Uddin[SUP] 1 [/SUP], Firzan Nainu[SUP] 3 [/SUP], Talha Bin Emran[SUP] 4 [/SUP], Jesus Simal-Gandara[SUP] 5 [/SUP]



Affiliations

Abstract

With an increasing fatality rate, severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has emerged as a promising threat to human health worldwide. Recently, the World Health Organization (WHO) has announced the infectious disease caused by SARS-CoV-2, which is known as coronavirus disease-2019 (COVID-2019), as a global pandemic. Additionally, the positive cases are still following an upward trend worldwide and as a corollary, there is a need for a potential vaccine to impede the progression of the disease. Lately, it has been documented that the nucleocapsid (N) protein of SARS-CoV-2 is responsible for viral replication and interferes with host immune responses. We comparatively analyzed the sequences of N protein of SARS-CoV-2 for the identification of core attributes and analyzed the ancestry through phylogenetic analysis. Subsequently, we predicted the most immunogenic epitope for the T-cell and B-cell. Importantly, our investigation mainly focused on major histocompatibility complex (MHC) class I potential peptides and NTASWFTAL interacted with most human leukocyte antigen (HLA) that are encoded by MHC class I molecules. Further, molecular docking analysis unveiled that NTASWFTAL possessed a greater affinity towards HLA and also available in a greater range of the population. Our study provides a consolidated base for vaccine design and we hope that this computational analysis will pave the way for designing novel vaccine candidates.

Keywords: COVID-19; SARS-CoV-2; bioinformatics; epitope; immunoinformatics; nucleocapsid protein; vaccine.
 
Back
Top Bottom